Sinovac expanded its international market access for influenza vaccines with approvals in countries like Pakistan and Chile.
The company's strategic developments in 2023 included successful joint ventures in vaccine production in Türkiye and Latin America, positioning Sinovac as a key player in vaccine R&D and production.